SABCS 2020
LocationOnline
- Starts: 8 December 2020
- Ends: 11 December 2020
- Website: Click to view
Almac Diagnostic Services is delighted that Shane Stecklein, MD, PhD of The University of Kansas Health System, will present Almac Diagnostic Services DDIR signature and claraT data when discussing the classification of triple negative breast cancer (TNBC) in the SWOG S9313 adjuvant trial on Thursday 10 Dec from 9am.
The event is taking place virtually between 8-11 December 2020.
About SABCS 2020
This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.
The scientific program consists of formal lectures by experts in clinical and basic research, selected slide and poster presentations, forums and case discussions.